OQZ
- Product code
- OQZ
- Device name
- Anti-Mutated Citrullinated Vimentin Igg
- Device class
- Class 2
- 21 CFR
- 21 CFR 866.5775
- Medical specialty
- Immunology
- Marketing pathway
- 510(K)
- Flag
- Third-party review eligible
- 510(k) clearances (all years, FDA)
- 1 (all years; only the last 3 years are listed here)
FDA classification definition
For the semi-quantitative measurement of IgG class autoantibodies against mutated citrullinated vimentin (MCV) in human serum or plasma.
Official FDA classification page: OQZ
Classification and pathway per current FDA publications. Data from openFDA (CC0).